Associate Director US Commercial FP&A

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.

Reporting to the Senior Director of US Commercial Finance, the Associate Director US Commercial FP&A will be a key member of the US FP&A team supporting the growing US commercial business. S/he will act as a strategic partner to the US organization. S/he will play a critical role in the revenue forecasting and financial planning process focusing on value creation and aligning resources with strategic priorities. S/he will be actively involved in the launch plan projects including providing financial support to key functional areas critical to the launch plan. S/he will be responsible for participating in the monthly close process and supporting certain aspects of the close working with US Accounting. This is a hybrid role based in Boston with being in the office usually 2 days/week at minimum.

Roles and Responsibilities:

• Strategic partnering: collaborate with US Indication Strategy Teams and cross-functional partners to develop and communicate accurate long-term patient / volume / revenue forecasts
• Support model enhancements to ensure forecasts for in-line & launch products reflect strategic direction of each indication (e.g., market segmentation, patient flow, etc.)
• Collaborate with Market Research to plan & design studies that provide key forecast inputs (e.g., demand study)
• Partner with Market Access to incorporate latest access assumptions, payer mix analyses, and all other gross-to-net variables
• Develop forecast scenarios to incorporate into supply planning and to quantify potential risks & opportunities
• Demonstrate a comprehensive understanding of the business drivers across the full commercial P&L brand partners (volume/sales, trade, COGS, marketing, SG&A) and price/volume mix analysis
• Collaborate with commercial teams to design and execute investment plans that drive growth and support the organization's strategic vision

Skills and Competencies:

The following skills and competences are mandatory for this position:

• Advanced commercial finance skill set in a fast-growing, ever-changing environment. Strong command of revenue drivers and US P&L dynamics
• Expert financial modeling and scenario design; able to simplify complexity and tell a clear, leadership-ready story with data
• Trusted and strategic business partner: possesses the technical expertise, communication skills and good judgement to provide executives with an objective and independent point of view on broader business issues
• Strong influence and stakeholder management across Commercial organization and global partners
• Strong learning agility. Enjoys and excels in environments where s/he must tackle and solve complex strategic business challenges and issues, incorporating the newest ideas, technologies, and approaches to business. Demonstrate a high level of emotional intelligence and self-awareness
• Continuous-improvement mindset; harmonization/standardization of processes and tools

Education, Experience and Qualifications:

• Bachelor's degree in Finance / Accounting / Economics
• Advanced degree or MBA preferred
• Biopharma or healthcare industry experience strongly preferred
• Minimum of 8+ years of overall combined finance, FP&A or accounting experience
• Advanced Analytical abilities, underscored by a track record of financial modeling, with a preference for expertise in revenue modeling

#LI-Hybrid

For applicants in the United States: The annual base salary hiring range for this position is $144,000.00 - $216,000.00 USD. This range reflects our good faith estimate at the time of posting. Individual compensation is determined using objective, inclusive, and job-related criteria such as relevant experience, skills, demonstrated competencies and internal equity. This means actual pay may differ from the posted range when justified by these factors. Because market conditions evolve, pay ranges are reviewed regularly and may be adjusted to remain aligned with external benchmarks.

This job is eligible to participate in our short-term and long-term incentive programs, subject to the terms and conditions of those plans and applicable policies. It also includes a comprehensive benefits package, including but not limited to retirement savings plans, health benefits and other benefits subject to the terms of the applicable plans and program guidelines.

At argenx, all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics. argenx is proud to be an equal opportunity employer.

Before you submit your application, CV or any other personal details to us, please review our argenx Privacy Notice for Job Applicants to learn more about how argenx B.V. and its affiliates ("argenx") will handle and protect your personal data. If you have any questions or you wish to exercise your privacy rights, please contact our Global Privacy Office by email at privacy@argenx.com.

If you require reasonable accommodation in completing your application, interviewing, or otherwise participating in the candidate selection process please contact us at hr.us@argenx.com. Only inquiries related to an accommodation request will receive a response.

---